Home
Login Register
> Return

Go to Forum     Add To MyCorner

Pharmesis IntlBFK

0.435 No Change

Group

Cash   

Cash

Singapore Dollar   

13-May 16:33

 

TRADING INFO

Open

-   

Buy

0.45   

High

-   

Low

-   

Previous Close

0.435   

Volume(K)

0.0   

Buy Volume(K)

0.4   

Sell Volume(K)

0.4   

 

KEY STOCK INFO

PE Ratio

1.4503503261657404   

Dividend Yield

-   

Price to Book Ratio

0.19926706367384334   

Market Cap

12006.0   

Enterprise Value

8094.0   

52 Weeks High

0.7   

52 Weeks Low

0.065   

RSI

12.08 ( Oversold )   

Williams %R

12.08 ( Oversold )   

 

COMPANY INFORMATION Financial Info by

SIC

MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS   

Address

5 KALLANG SECTOR #03-02 SINGAPORE 349279   

Phone

(65) 6743 7916   

Fax

(65) 6846 0766   

SIC

The Group is specialising in the manufacturing of pharmaceutical products in the form of tablets, granules and pills etc including TCM ("Traditional Chinese Medicine") formulated products for the treatment of illnesses relating to the liver and gall bladder.   

AUDITOR

ERNST & YOUNG LLP   

 

FINANICALS INFORMATION All values in $millions

  
    

Financial Year

2023-12-31   

Currency

CNY   
KEY RATIOS

Operating Margin(%)

-8.684   

Return on Equity Capital(%)

-8.921   

Net Profit Margin(%)

-10.864   

Current Ratio

1.087   

Debt to Capital at Book

0.192   
INCOME STATEMENT

EBITDA

-2121.0   

EBITDA

-4031.0   

Net Profit

-4958.0   

Ordinary Dividend

0.0   
BALANCE SHEET

Intangibles

1.323   

Fixed Assets

42.652   

Long Term Investments

0.0   

Stock/Inventories

15369.0   

Cash

9477.0   

Current Liabilities

30629.0   

Long Term Debt

0.0   

Provisions

0.0   

Minorities

0.0   

Total Shareholder Equity

54.19   
PER SHARE INFO

EBITDA per share

-0.077   

EBIT per share

-0.176   

Profit per share

-0.18   

Book Value per share

1.915   

Financial Year

2022-12-31   

Currency

CNY   
KEY RATIOS

Operating Margin(%)

-4.382   

Return on Equity Capital(%)

-6.08   

Net Profit Margin(%)

-7.068   

Current Ratio

1.115   

Debt to Capital at Book

0.169   
INCOME STATEMENT

EBITDA

-236.0   

EBITDA

-2235.0   

Net Profit

-3560.0   

Ordinary Dividend

0.0   
BALANCE SHEET

Intangibles

1.323   

Fixed Assets

43.396   

Long Term Investments

0.0   

Stock/Inventories

11086.0   

Cash

19718.0   

Current Liabilities

39595.0   

Long Term Debt

0.0   

Provisions

0.0   

Minorities

0.0   

Total Shareholder Equity

56.966   
PER SHARE INFO

EBITDA per share

-0.01   

EBIT per share

-0.137   

Profit per share

-0.155   

Book Value per share

2.419   

Financial Year

2022-12-31   

Currency

CNY   
KEY RATIOS

Operating Margin(%)

-4.382   

Return on Equity Capital(%)

-6.08   

Net Profit Margin(%)

-7.068   

Current Ratio

1.115   

Debt to Capital at Book

0.169   
INCOME STATEMENT

EBITDA

-236.0   

EBITDA

-2235.0   

Net Profit

-3560.0   

Ordinary Dividend

0.0   
BALANCE SHEET

Intangibles

1.323   

Fixed Assets

43.396   

Long Term Investments

0.0   

Stock/Inventories

11086.0   

Cash

19718.0   

Current Liabilities

39595.0   

Long Term Debt

0.0   

Provisions

0.0   

Minorities

0.0   

Total Shareholder Equity

56.966   
PER SHARE INFO

EBITDA per share

-0.01   

EBIT per share

-0.137   

Profit per share

-0.155   

Book Value per share

2.419   
Important: Please read our Terms and Conditions and Privacy Policy .